argenx SE (ARGX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ARGX Revenue Growth
Revenue Breakdown
ARGX's revenue distribution by segment and geography
By Geography
ARGX Revenue Analysis (2014–2025)
As of May 8, 2026, argenx SE (ARGX) generated trailing twelve-month (TTM) revenue of $5.60 billion, reflecting explosive growth of +78.7% year-over-year. The most recent quarter (Q4 2025) recorded $2.41 billion in revenue, up 153.8% sequentially.
Looking at the longer-term picture, ARGX's 5-year compound annual growth rate (CAGR) stands at +151.7%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $4.16 billion in 2025, representing a new all-time high.
When compared to Healthcare sector peers including RARE (+13.3% YoY), ALNY (+82.6% YoY), and SRPT (-2.2% YoY), ARGX has underperformed the peer group in terms of revenue growth. Compare ARGX vs RARE →
ARGX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARGXCurrent | $5.6B | +78.7% | +151.7% | 23.4% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% | |
 ALNY | $3.7B | +82.6% | +49.8% | 13.5% | |
 SRPT | $2.2B | -2.2% | +32.4% | -29.9% | |
 BMRN | $3.2B | +9.9% | +11.6% | 16.6% | |
 IONS | $944M | +47.5% | +5.3% | -40.5% |
ARGX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.16B | +90.1% | $3.71B | 89.1% | $972.5M | 23.4% |
| 2024 | $2.19B | +78.6% | $1.96B | 89.6% | $-21,654,000 | -1.0% |
| 2023 | $1.23B | +198.6% | $1.11B | 90.4% | $-425,049,000 | -34.7% |
| 2022 | $410.7M | -17.4% | $381.3M | 92.8% | $-720,341,000 | -175.4% |
| 2021 | $497.3M | +1105.7% | $497.3M | 100.0% | $-348,746,000 | -70.1% |
| 2020 | $41.2M | -47.4% | $41.2M | 100.0% | $-477,617,000 | -1158.1% |
| 2019 | $78.5M | +219.3% | $78.5M | 100.0% | $-198,892,000 | -253.5% |
| 2018 | $24.6M | -43.8% | $24.6M | 100.0% | $-93,627,000 | -381.0% |
| 2017 | $43.7M | +182.3% | $43.7M | 100.0% | $-27,512,000 | -63.0% |
| 2016 | $15.5M | +106.5% | $15.5M | 100.0% | $-22,523,000 | -145.6% |
Full ARGX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See ARGX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARGX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARGX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonARGX — Frequently Asked Questions
Quick answers to the most common questions about buying ARGX stock.
Is ARGX's revenue growth accelerating or slowing?
ARGX revenue is accelerating at +78.7% year-over-year, exceeding the 5-year CAGR of +151.7%. TTM revenue reached $5.6B. Growth momentum has increased versus prior periods.
What is ARGX's long-term revenue growth rate?
argenx SE's 5-year revenue CAGR of +151.7% reflects the sustained expansion pattern. Current YoY growth of +78.7% is above this long-term average.
How is ARGX's revenue distributed by segment?
ARGX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.